Skip to content

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

The International Spontaneous Coronary Artery Dissection "iSCAD" Registry (SCAD)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04496687
Enrollment
2000
Registered
2020-08-03
Start date
2019-03-08
Completion date
2026-12-31
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous Coronary Artery Dissection

Keywords

spontaneous coronary artery dissection (SCAD), myocardial infarction, sudden cardiac arrest, acute coronary syndrome

Brief summary

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by an experienced and centralized coordinating center in an effort to increase the pace of participant recruitment, and thereby increase statistical power of studies related to SCAD. The ultimate goal of iSCAD Registry is to facilitate the development of best practices and clinical guidelines for preventing SCAD or its recurrence. This observational study will be prospective and retrospective in its recruitment and will collect clinical information to better understand the natural history and prognosis for SCAD.

Detailed description

Spontaneous Coronary Artery Dissection (SCAD) is an under-diagnosed cause of acute coronary syndrome (ACS), myocardial infarction (MI) and sudden cardiac arrest. The inner lining of the coronary artery splits and allows blood to seep into the adjacent layer, forming a blockage (hematoma), or the artery continues to tear, creating a flap of tissue that blocks blood flow in the artery. SCAD strikes generally healthy, younger individuals (average age 42) who do not have traditional cardiac risk factors. Warning signs of SCAD encompass the full range of ACS and MI symptoms, from vague to classic. The cause of SCAD is currently unknown and the psychosocial impact of SCAD is traumatizing. The work of the iSCAD Registry will encompass the physical and psychosocial study of SCAD.

Interventions

None listed

Sponsors

SCAD Alliance
Lead SponsorOTHER
PERFUSE Study Group
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants with a new diagnosis of SCAD or a history of confirmed or suspected SCAD will be prospectively recruited from either: 1. Inpatient wards of the enrolling medical centers during the acute presentation of SCAD, or 2. Outpatient cardiovascular clinics of enrolling medical centers. Participants must be: * 18 years of age or older * Diagnosis of SCAD or history of SCAD based on coronary angiography, either catheter-based or coronary CTA * Suspected SCAD by coronary angiography

Exclusion criteria

1. Coronary dissection in association with atherosclerosis or as a result of iatrogenic injury 2. Inability to provide informed consent 3. Inability to complete study-related patient questionnaires 4. Inability to understand and complete patient questionnaires independently

Design outcomes

Primary

MeasureTime frameDescription
Descriptive DataContinuous time frame following index event for an average of 3 years from study contact dateParticipant demographic, historical, clinical characteristics, and treatment data
Clinical OutcomesContinuous time frame following index event for an average of 3 years from study contact dateProspectively collected long-term outcomes including recurrent myocardial infarction, hospitalization, heart failure, stroke or transient ischemic attack, arrhythmia, and all cause mortality
Psychosocial OutcomesContinuous time frame following index event for an average of 3 years from study contact dateProspectively collected data on participant's mental health using validated questionnaires

Countries

Australia, United States

Contacts

STUDY_CHAIREsther Kim, MD

Chair, Steering Committee

PRINCIPAL_INVESTIGATORMalissa Wood, MD

Member, Steering Committee

PRINCIPAL_INVESTIGATORSahar Naderi, MD

Member, Steering Committee

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026